Patents by Inventor Mary Frances Fitzgerald

Mary Frances Fitzgerald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhaled combination therapy
    Patent number: 9084799
    Abstract: There is provided the use of a methylxanthine derivative such as theophylline and a steroid in a synergistic combination for the treatment of chronic obstructive pulmonary disease, wherein the combination is administered by the inhaled route for pulmonary delivery.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: July 21, 2015
    Assignee: Pulmagen Therapeutics (Synergy) Limited
    Inventors: Justian Craig Fox, Mary Frances Fitzgerald, Harry Finch
  • Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases
    Patent number: 8431553
    Abstract: There is provided the use of a methylxanthine derivative such as theophylline and a steroid in a synergistic combination for the treatment of chronic obstructive pulmonary disease, wherein the combination is administered by the inhaled route for pulmonary delivery.
    Type: Grant
    Filed: February 13, 2006
    Date of Patent: April 30, 2013
    Assignee: Pulmagen Therapeutics (Synergy) Limited
    Inventors: Justian Craig Fox, Mary Frances Fitzgerald, Harry Finch
  • Inhaled combination therapy
    Patent number: 8426393
    Abstract: There is provided the use of a methylxanthine derivative such as theophylline and a steroid in a synergistic combination for the treatment of chronic obstructive pulmonary disease, wherein the combination is administered by the inhaled route for pulmonary delivery.
    Type: Grant
    Filed: August 24, 2010
    Date of Patent: April 23, 2013
    Assignee: Pulmagen Therapeutics (Synergy) Limited
    Inventors: Justian Craig Fox, Mary Frances Fitzgerald, Harry Finch
  • Inhaled combination therapy
    Publication number: 20100324002
    Abstract: There is provided the use of a methylxanthine derivative such as theophylline and a steroid in a synergistic combination for the treatment of chronic obstructive pulmonary disease, wherein the combination is administered by the inhaled route for pulmonary delivery.
    Type: Application
    Filed: August 24, 2010
    Publication date: December 23, 2010
    Inventors: Justian Craig Fox, Mary Frances Fitzgerald, Harry Finch
  • Dihydropyrimidone Multimers and Their Use as Human Neutrophil, Elastase Inhibitors
    Publication number: 20090105268
    Abstract: A compound of formula M-L-M (I) wherein L is a linker and each M is independently a group of formula (II) is useful in therapy, e.g. of respiratory diseases.
    Type: Application
    Filed: June 26, 2006
    Publication date: April 23, 2009
    Inventors: Harry Finch, Christine Edwards, Nicholas Charles Ray, Mary Frances Fitzgerald
  • Combination of Methylxanthine Compounds and Steroids to Treat Chronic Respiratory Diseases
    Publication number: 20080318913
    Abstract: There is provided the use of a methylxanthine derivative such as theophylline and a steroid in a synergistic combination for the treatment of chronic obstructive pulmonary disease, wherein the combination is administered by the inhaled route for pulmonary delivery.
    Type: Application
    Filed: February 13, 2006
    Publication date: December 25, 2008
    Inventors: Justian Craig Fox, Mary Frances Fitzgerald, Harry Finch